Furthermore, DNMT3A and JAK2 mutations, now known to promote atherosclerosis and HF, drive the proliferation of bone marrow cells with proinflammatory characteristics (24, 46, 53, 65, 73, 74). This evidence concerns the gene JAK2 and atherosclerosis.